November 24, 2021 Five of the COVID-19 research projects funded through a special round of Gillings Innovation Laboratory awards (GILs) have now been completed, and the two remaining are expected to wrap in early 2022. Their work has been critical in influencing local and global pandemic response efforts through policy, practice and community engagement.
November 16, 2021 Nine academics from the Gillings School were recently named to the 2021 Highly Cited Researchers list from Clarivate. The highly anticipated annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.
November 11, 2021 RTI International, a nonprofit research institute, announced the winner of its Forethought Research Collaboration Challenge. The group of researchers working to combat the next pandemic, led by experts at the University of North Carolina at Chapel Hill, will receive $5 million in seed funding to produce antiviral drugs for the future.
November 10, 2021 People who enjoy parks and trails in Chapel Hill and surrounding areas should be on the lookout for ticks, according to recent findings from epidemiology researchers at the Gillings School.
November 2, 2021 A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.
November 1, 2021 MERS, caused by a coronavirus strain of the same name, holds clues for respiratory diseases like COVID-19.
October 29, 2021 Researchers found that people experiencing incarceration in North Carolina who were assigned to a therapeutic diversion unit instead of restrictive housing were at least three times less likely to commit further infractions, harm themselves or require inpatient mental health treatment.
October 14, 2021 Between 2015 and 2019, North Carolina saw an increase in overdose deaths that involved multiple drugs, highlighting the rapidly changing nature of drug overdoses in the state.
October 1, 2021 University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.
August 30, 2021 The study reports on how frequently COVID-19 spreads to other people living in the same household as someone diagnosed with the illness. The researchers emphasize that having many people living in one household is a major factor in infection risk, which disproportionately affects communities of color.